---
schema_version: "secwatch.filing_event.v1"
accession: "0000021665-26-000003"
form_type: "8-K"
ticker: "CL"
cik: "0000021665"
company_name: "COLGATE PALMOLIVE CO"
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T06:09:52.964426+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment

## Summary
- Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.
- GAAP diluted EPS $2.63, down 25% YoY due to goodwill/intangibles impairment in skin health business.
- Base Business EPS $3.69, up 3% YoY; record net cash from operations $4,198M.
- Returned $2.9B to shareholders via dividends and share repurchases in FY2025.

## SEC filing metadata
- accession: 0000021665-26-000003
- form_type: 8-K
- ticker: CL
- cik: 0000021665
- company_name: COLGATE PALMOLIVE CO
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21665/000002166526000003/0000021665-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21665/000002166526000003/cl-20260130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021665-26-000003
- JSON: https://secwatch.observer/filing/0000021665-26-000003.json
- Plain text: https://secwatch.observer/filing/0000021665-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.